Merck Updates Plans for Headquarters Move in New Jersey
Dateline City:
WHITEHOUSE STATION, N.J.
Company to Close Summit Campus; Move Global HQ to Kenilworth
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
today announced plans to move its global headquarters from Whitehouse
Station, N.J., to its existing facilities in Kenilworth, N.J. The
company had previously announced that it would close its Whitehouse
Station building and relocate its global headquarters to Su...
Source: Merck.com - Corporate News - October 1, 2013 Category: Pharmaceuticals Tags: Corporate News Latest News Source Type: news
Merck Announces Global Initiative to Sharpen Commercial and R&D Focus
Dateline City:
WHITEHOUSE STATION, N.J.
Company Redesigns Operating Model; Reduces Cost Base
Initiative targets net reduction in annual operating expenses of approximately $2.5 billion by the end of 2015
Plan includes new workforce reductions of approximately 8,500 positions, in addition to pending, previously announced reductions
Company reaffirmed 2013 full-year non-GAAP EPS target of $3.45 to $3.55; revised GAAP EPS range to $1.58 to $1.82
...
Source: Merck.com - Corporate News - October 1, 2013 Category: Pharmaceuticals Tags: Corporate News Latest News Source Type: news
Merck to Hold Third-Quarter 2013 Sales and Earnings Conference Call on October 28
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
will hold its third-quarter 2013 sales and earnings conference call with
institutional investors and analysts at 8:00 a.m. EDT on Monday, Oct.
28. During the call, company executives will provide an overview of
Merck’s performance for the quarter.
Language:
English
Contact:
...
Source: Merck.com - Corporate News - September 27, 2013 Category: Pharmaceuticals Tags: Corporate News Financial News Latest News Source Type: news
OXYTROL® FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women, Now Available Nationwide
Dateline City:
WHITEHOUSE STATION, N.J.
Offers More Than 20 Million Female Sufferers Newfound Sense of Control over Condition
Merck Consumer Care, the makers of OXYTROL FOR WOMEN, announced today that the more than 20 million women suffering from overactive bladder (OAB) can now gain better control of their condition with a visit to the feminine care aisle at their local retailer. OXYTROL FOR WOMEN is a thin, flexible patch that is discreetly applied to the abdomen, hip or buttock once every four days for the ...
Source: Merck.com - Corporate News - September 25, 2013 Category: Pharmaceuticals Tags: Merck Merck Consumer Care MRK MSD OAB overactive bladder Oxytrol Consumer Care News Corporate News Latest News Source Type: news
Merck Named To 2013 Working Mother 100 Best Companies
Dateline City:
WHITEHOUSE STATION, N.J.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that it has been named as one of the Working Mother 100 Best Companies for 2013.
Honored on the list for the 26th year, Merck is among the 100 companies recognized for their commitment to progressive workplace programs, including female representation, compensation, child care, flexibility, time off and leave, family-friendly programs and company culture.
Language:
English
Tic...
Source: Merck.com - Corporate News - September 17, 2013 Category: Pharmaceuticals Authors: Maria.tortoreto at merck.com Tags: diversity Dottie Brienza Merck MRK MSD talent Working Mother Corporate News Corporate Responsibility News Latest News Source Type: news
Merck to Present at the Morgan Stanley Global Healthcare Conference
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced today that Roger M. Perlmutter, executive vice president and
president, Merck Research Laboratories, is scheduled to present at the
Morgan Stanley Global Healthcare Conference in New York on Sept. 11 at
8:00 a.m. EDT. Investors, analysts, members of the media and the general
public are invited to listen to a live audio webcast of the presentation
at http://www.merck....
Source: Merck.com - Corporate News - September 10, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Latest News Source Type: news
Merck and Israel’s Maccabi Healthcare to Leverage Unique Real-World Database to Inform Novel Health Approaches
Dateline City:
WHITEHOUSE STATION, N.J. and TEL AVIV, ISRAEL
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Maccabi Healthcare Services, atwo million-member health care provider in Israel, are starting a new, multi-yearagreement to leverage real-world data from Maccabi’s unique longitudinal database to inform novel, patient-centered health approaches.
Maccabi and Merck will apply technical and information research capabilities to draw insights from Maccabi’s data to support personalized health care delivery strategies across several ther...
Source: Merck.com - Corporate News - September 9, 2013 Category: Pharmaceuticals Authors: Maria.tortoreto at merck.com Tags: Maccabi Merck MRK MSD Sachin Jain Varda Shalev Corporate News Latest News Source Type: news
Merck’s Durham Site Receives U.S. FDA Licensure for Varicella Bulk
Dateline City:
DURHAM, N.C.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture bulk varicella at the company’s site in Durham, N.C., for use in Merck’s vaccines to protect against chickenpox and shingles. The approval will enable the site to produce bulk varicella supply for the U.S. and help boost Merck’s overall global supply capabilities.
In 2010, the site was approved to produce finished chickenpox vaccines.
Language:
...
Source: Merck.com - Corporate News - September 4, 2013 Category: Pharmaceuticals Authors: Maria.tortoreto at merck.com Tags: chickenpox durham herpes zoster john howell julie gerberding maurice r. hilleman Merck MMD MRK MSD pneumovax shingles varivax willie deese zostavax Vaccine News Corporate News Latest News Source Type: news
Merck and Her Campus Ask College-Aged Women to Take the Pledge to Plan It Forward For Their Futures by Evaluating How Today’s Decisions Can Affect Tomorrow
Dateline City:
WHITEHOUSE STATION, N.J.
Program Encourages Women to Plan their Future
On- or off-campus housing? Which major to declare? An internship or work study? These are questions often debated by college-aged women at the start of a new school year.
Language:
English
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more (Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - August 1, 2013 Category: Pharmaceuticals Authors: Maria.tortoreto at merck.com Tags: Merck MRK MSD Corporate News Latest News Source Type: news
Merck Publishes 2012 Global Corporate Responsibility Report
Dateline City:
WHITEHOUSE STATION, N.J.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today issued its 2012 global corporate responsibility report.
Language:
English
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more (Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - July 31, 2013 Category: Pharmaceuticals Authors: Maria.tortoreto at merck.com Tags: Corporate Responsibility CSR Merck MRK MSD Corporate News Corporate Responsibility News Latest News Source Type: news
Merck Announces Second-Quarter 2013 Financial Results
Dateline City:
WHITEHOUSE STATION, N.J.
2013 Second-Quarter Non-GAAP EPS of $0.84, Excluding Certain Items; GAAP EPS of $0.30
Worldwide Sales were $11.0 Billion, a Decrease of 11 Percent Reflecting the Unfavorable Impact of Patent Expiries and a 3 Percent Negative Impact from Foreign Exchange Partially Offset by Global Performance of Human Health Products
Growth in Key Franchises Including Vaccines, Diabetes and Immunology
Continue...
Source: Merck.com - Corporate News - July 30, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Latest News Source Type: news
Merck Applauds Colombia for First PAHO/WHO Verification of Elimination of River Blindness
Dateline City:
WHITEHOUSE STATION, N.J.
Historic Milestone Reflects Successful Collaboration Among MECTIZAN® Donation Program and Partners
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
applauds the government of Colombia whose work with the MECTIZAN®
Donation Program and The Carter Center-sponsored Onchocerciasis
Elimination Program for the Americas led to today’s Pan American Health
Organ...
Source: Merck.com - Corporate News - July 29, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Corporate Responsibility News Latest News Source Type: news
Merck Announces Fourth-Quarter 2013 Dividend
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today
announced that the Board of Directors has declared a quarterly dividend
of $0.43 per share on the company’s common stock for the fourth quarter
of 2013. Payment will be made on Oct. 7, 2013, to stockholders of record
at the close of business on Sept. 16, 2013.
About Merck
Language:
English
Cont...
Source: Merck.com - Corporate News - July 24, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Source Type: news
Merck to Hold Second-Quarter 2013 Sales and Earnings Conference Call on July 30
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
will hold its second-quarter 2013 sales and earnings conference call
with institutional investors and analysts at 8:00 a.m. EDT on Tuesday,
July 30. During the call, Kenneth C. Frazier, chairman and chief
executive officer; Peter N. Kellogg, executive vice president and chief
financial officer; and Adam H. Schechter, president, Global Human
Health, will provide an overvi...
Source: Merck.com - Corporate News - June 28, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Source Type: news
Merck to Present at the Sanford C. Bernstein Strategic Decisions Conference
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced today that Kenneth C. Frazier, chairman and chief executive
officer, Merck, is scheduled to present at the Sanford C. Bernstein
Strategic Decisions Conference in New York on May 31 at 9:00 a.m. EDT.
Investors, analysts, members of the media and the general public are
invited to listen to a live audio webcast of the presentation at http://www.merck.com/investors/events...
Source: Merck.com - Corporate News - May 30, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Latest News Source Type: news
